SEC Comment Letter for Anixa Biosciences Inc (ANIX) (CIK 0000715446) (ANIX) — Jun 17, 2014
Anixa Biosciences Inc (ANIX) (CIK 0000715446)
Date: June 17, 2014 · CIK: 0000715446 · Accession: 0000000000-14-030786
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-11254
Letter
June 17, 2014 Via E -Mail Robert A. Berman President and Chief Executive Officer CopyTele, Inc. 900 Walt Whitman Road Melville, New York 11747
Re: CopyTele, Inc. Preliminary Proxy Statement on Schedule 14 A Filed on June 3, 2014 File No. 000-11254
Dear Mr. Berman :
We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/S/ Maryse Mills -Apenteng
Show Raw Text
June 17, 2014 Via E -Mail Robert A. Berman President and Chief Executive Officer CopyTele, Inc. 900 Walt Whitman Road Melville, New York 11747 Re: CopyTele, Inc. Preliminary Proxy Statement on Schedule 14 A Filed on June 3, 2014 File No. 000-11254 Dear Mr. Berman : We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /S/ Maryse Mills -Apenteng Maryse Mills -Apenteng Special Coun sel